Volker Liebenberg, Director Medical Affairs EMEA at Illumina, is a physician with more than 15 years of experience in the development and commercialization of in-vitro diagnostics (IVD). His focus has been on implementation of innovative technologies, especially molecular diagnostics, to improve healthcare at scale. Prior to illumina he was with several molecular diagnostic companies including QIAGEN GmbH, Thermo Fisher Scientific Inc. and Epigenomics AG, where he gained experience and drove implementation of novel biomarkers and IVD-products across various indications in oncology, infectious disease and prenatal screening. Dr. Liebenberg’s passion is to improve patient care by innovating diagnostic technologies and translating them into routine care. Based in Berlin, he interacts with societies, leading medical institutions and companines across the globe driving the generation and dissemination of evidence proving the value of diagnostics.